Searched for
HEALTHCARE SECTOR GROWTH
FMCG, healthcare in line for strong show in FY27: BrickworksIndia's consumer goods and healthcare sectors are poised for robust growth this fiscal year, driven by tax relief, increasing consumer spen...
Japan emerges as largest APAC contributor to India's GCC ecosystem: DeloitteJapan is now India's top contributor to the Asia-Pacific GCC sector, with over 100 Japanese companies establishing centers. These hubs are ...
Consumer & healthcare best placed most sectors stable, says BrickworkIndia's consumer goods and healthcare sectors are poised for strong growth this fiscal year, fueled by tax cuts, rising consumer demand, an...
Sitharaman urges French firms to invest in India's AI, clean energy pushUnion Finance Minister Nirmala Sitharaman urged French businesses to boost investments in India, highlighting vast opportunities in AI, cle...
For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
How Jewar Airport could trigger a Gurugram-like boom in FaridabadFaridabad, once a quiet NCR real estate market, is poised for rapid transformation driven by the upcoming Noida International Airport. Impr...
Bank of Baroda settles NMC Health dispute for $600 million; Q1 credit grows 17%Bank of Baroda has settled a significant legal dispute with NMC Health entities for USD 600 million, resolving claims under UAE and UK regu...
CSM Technologies shares list flat at IPO price of Rs 113 on BSE, NSEThe public issue, which was open for subscription between June 24 and June 29, was subscribed 1.37 times overall. The retail investor porti...
The surprising reason India's most expensive stocks often keep risingIndian stocks defy logic, with expensive companies consistently outperforming. This trend, observed over 15 years, sees sectors like defenc...
Sticky inflation clouds rate outlook, but AI and earnings keep markets resilient: Santosh RaoThe AI-driven market rally is expanding beyond tech, with healthcare, financials, and transportation sectors showing robust participation, ...
Cupid shares gain 2% as firm raises FY27 guidance, expects Q1 revenue to top Rs 150 croreCupid shares gained 2% as the company anticipates a record Q1 FY27 revenue exceeding Rs 150 crore. Buoyed by strong market visibility, Cupi...
India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
Is Rs 2 crore enough for retirement? See the monthly income you can generate and how long your corpus may lastRetirement planning India: Retiring with Rs 2 crore? Experts advise a prudent 3.5-4% withdrawal rate, yielding around Rs 60,000-Rs 70,000 m...
Persistent's Nagarro deal faces near-term doubts, but long-term story stays strong: Piyush PandeyPersistent Systems' acquisition of Nagarro triggered an 11% stock drop, with investors worried about integration and margins. However, mark...
Govt pledges extra Rs 30,000 crore for NIIF, move to spur infra investments, says finance ministryThe Indian government has boosted its commitment to the National Investment and Infrastructure Fund (NIIF) by an additional Rs 30,000 crore...
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...